A proinflammatory tumor that activates protein degradation sensitizes rats to catabolic effects of endotoxin

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 4 52-4, 2005, Pages

  Mackenzie, Michelle L ^a   Bedard, Nathalie ^b   Wing, Simon S ^b   Baracos, Vickie E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Inflammation; Muscle wasting; Ubiquitin proteolytic pathway

Indexed keywords

ENDOTOXIN; MESSENGER RNA; MUSCLE PROTEIN; SODIUM CHLORIDE; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2 14K; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CACHEXIA; CATABOLISM; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; INFLAMMATION; MALE; MUSCLE ATROPHY; MUSCLE MASS; NITROGEN BALANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN METABOLISM; RAT; WEIGHT REDUCTION; YOSHIDA SARCOMA;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPOPOLYSACCHARIDES; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEOPLASM PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 25144437375     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00050.2005     Document Type: Article

References (38)

1. Baracos VE. Hypercatabolism and hypermetabolism in wasting states. Curr Opin Clin Nutr Metab Care 5: 237-239, 2002.
2. Baracos VE. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition 16: 1015-1018, 2000.
3. Baracos VE, DeVivo C, Hoyle DH, and Goldberg AL. Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am J Physiol Endocrinol Metab 268: E996-E1006, 1995.
4. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan ZQ, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD, and Glass DJ. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294: 1704-1708, 2001.
5. Bradstreet RB (Editor). The Kjeldahl Method for Organic Nitrogen. New York: Academic, 1965, p. 1-8.
6. Chai J, Wu Y, and Sheng ZZ. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit Care Med 31: 1802-1807, 2003.
7. Combaret L, Tilignac T, Claustre A, Voisin L, Taillandier D, Obled C, Tanaka K, and Attaix D. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats. Biochem J 361: 185-192, 2002.
8. Combaret L, Ralliere C, Taillandier D, Tanaka K, and Attaix D. Manipulation of the ubiquitin-proteasome pathway in cachexia: pentoxifylline suppresses the activation of 20S and 26S proteasomes in muscle from tumor-bearing rats. Mol Biol Rep 26: 95-101, 1999.
9. Costelli P, Carbo N, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Argiles JM, and Baccino FM. Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993.
10. Falconer JS, Fearon KC, Ross JA, Elton R, Wigmore SJ, Garden OJ, and Carter DC. Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer 75: 2077-2082, 1995.
11. Fan J, Marshall JC, Jimenez M, Shek PN, Zagorski J, and Rotstein OD. Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide. J Immunol 161: 440-447, 1998.
12. Fearon KC, McMillan DC, Preston T, Winstanley FP, Cruickshank AM, and Shenkin A. Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg 213: 26-31, 1991.
13. Fearon KC, Hansell DT, Preston T, Plumb JA, Davies J, Shapiro D, Shenkin A, Calman KC, and Burns HJ. Influence of whole body protein turnover rate on resting energy expenditure in patients with cancer. Cancer Res 48: 2590-2595, 1988.
14. Ferrando AA, Stuart CA, Sheffield-Moore M, and Wolfe MM. Inactivity amplifies the catabolic response of skeletal muscle to cortisol. J Clin Endocrinol Metab 84: 3515-3521, 1999.
15. Fink MP and Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 49: 186-196, 1990.
16. Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol Endocrinol Metab 260: E727-E730, 1991.
17. Grossie VB and Mailman D. Influence of the Ward colon tumor on the host response to endotoxin. J Cancer Res Clin Oncol 123: 189-194, 1997.
18. Homsi J, Walsh D, Panta R, Lagman R, Nelson KA, and Longworth DL. Infectious complications of advanced cancer. Support Care Cancer 8: 487-492, 2000.
19. Inagaki J, Rodriguez V, and Bodey GP. Causes of death in cancer patients. Cancer 33: 568-573, 1974.
20. Kwak KS, Zhou X, Solomon V, Baracos VE, Davis J, Bannon AW, Boyle WJ, Lacey DL, and Han HQ. Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3α-II during cancer cachexia. Cancer Res 64: 8193-8198, 2004.
21. Lecker SH, Jagoe MT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE, and Goldberg AL. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 18: 39-51, 2004.
22. Lecker SH. Ubiquitin-protein ligases in muscle wasting: multiple parallel pathways? Curr Opin Clin Nutr Metab Care 6: 271-275, 2003.
23. Llovera M, Garcia-Martinez C, Lopez-Soriano J, Agell N, Lopez-Soriano FJ, Garcia I, and Argiles JM. Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. Cancer Lett 130: 19-27, 1998.
24. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, and Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238-241, 1997.
25. Mathison JC, Wolfson E, and Ulevitch RJ. Participation of tumor necrosis factor in the mediation of gram negative lipopolysaccharide-induced injury in rabbits. J Clin Invest 81: 1925-1937, 1988.
26. Matthys P, Heremans H, Opdenakker G, and Billiau A. Anti-interferon- γ antibody treatment, growth of lewis lung tumours in mice and tumour-associated cachexia. Eur J Cancer 27: 182-187, 1991.
27. Nagy-Argen S and Haley HB. Management of infections in palliative care patients with advanced cancer. J Pain Symptom Manage 24: 64-70, 2002.
28. National Research Council. Nutrient Requirements of Laboratory Animals (4th Ed.). Washington, DC. National Academy of Science, 1995.
29. Powers KA, Woo J, Khadaroo RG, Papia G, Kapus A, and Rotstein OD. Hypertonic resuscitation of hemorrhagic shock upregulates the anti-inflammatory response by alveolar macrophages. Surgery 134: 312-318, 2003.
30. Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, and O'Brien MER. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90: 1905-1911, 2004.
31. Scott HR, McMillan DC, Forrest LM, Brown DJ, McArdle CS, and Milroy R. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small lung cancer. Br J Cancer 87: 264-267, 2002.
32. Sedgwick GW, Fenton TF, and Thompson JR. Effect of protein precipitating agents on the recovery of plasma free amino acids. Can J Anim Sci 71: 953-957, 1991.
33. Staal-van den Brekel AJ, Schols AM, Dentener MA, ten Velde GP, Buurman WA, and Wouters EF. The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma. Br J Cancer 76: 1630-1635, 1997.
34. Strelkov AB, Fields AL, and Baracos VE. Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats. Am J Physiol Cell Physiol 257: C261-C269, 1989.
35. Tessitore L, Costelli P, and Baccino FM. Humoral mediation for cachexia in tumour-bearing rats. Br J Cancer 67: 15-23, 1993.
36. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer 2: 862-871, 2002.
37. Vigano A, Dorgan M, Buckingham J, Bruera E, and Suarez-Almazor M. Survival prediction in terminal cancer patients: a systematic review of the medical literature. Palliat Med 14: 363-374, 2000.
38. Zhang Y, Pilon G, Marette A, and Baracos VE. Cytokines and endotoxin induce cytokine receptors in skeletal muscle. Am J Physiol Endocrinol Metab 279: E196-E205, 2000.